119 related articles for article (PubMed ID: 8322016)
41. WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome.
Cilloni D; Saglio G
Acta Haematol; 2004; 112(1-2):79-84. PubMed ID: 15179007
[TBL] [Abstract][Full Text] [Related]
42. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
Scholz C; Nimmrich I; Burger M; Becker E; Dörken B; Ludwig WD; Maier S
Ann Hematol; 2005 Apr; 84(4):236-44. PubMed ID: 15538567
[TBL] [Abstract][Full Text] [Related]
43. Complete exon structure of the ALL1 gene.
Rasio D; Schichman SA; Negrini M; Canaani E; Croce CM
Cancer Res; 1996 Apr; 56(8):1766-9. PubMed ID: 8620491
[TBL] [Abstract][Full Text] [Related]
44. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
45. Mutations of the RAS genes in childhood acute myeloid leukemia, myelodysplastic syndrome and juvenile chronic myelocytic leukemia.
Sheng XM; Kawamura M; Ohnishi H; Ida K; Hanada R; Kojima S; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
Leuk Res; 1997 Aug; 21(8):697-701. PubMed ID: 9379676
[TBL] [Abstract][Full Text] [Related]
46. Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features.
Stevens-Kroef M; Poppe B; van Zelderen-Bhola S; van den Berg E; van der Blij-Philipsen M; Geurts van Kessel A; Slater R; Hamers G; Michaux L; Speleman F; Hagemeijer A
Leukemia; 2004 Jun; 18(6):1108-14. PubMed ID: 15085164
[TBL] [Abstract][Full Text] [Related]
47. Utility of molecular genetic analysis of bcr rearrangement in the diagnosis of chronic myeloid leukemia.
Benn P; Soper L; Eisenberg A; Silver RT; Coleman M; Cacciapaglia B; Bennett L; Baird M; Silverstein M; Berger C
Cancer Genet Cytogenet; 1987 Nov; 29(1):1-7. PubMed ID: 2822224
[TBL] [Abstract][Full Text] [Related]
48. Molecular diagnosis and monitoring of acute myeloid leukemia.
Biondi A; Rambaldi A
Leuk Res; 1996 Oct; 20(10):801-7. PubMed ID: 8960104
[TBL] [Abstract][Full Text] [Related]
49. Analysis of ras gene mutations and methylation state in human leukemias.
Browett PJ; Norton JD
Oncogene; 1989 Aug; 4(8):1029-36. PubMed ID: 2668844
[TBL] [Abstract][Full Text] [Related]
50. p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression.
Lübbert M; Miller CW; Crawford L; Koeffler HP
J Exp Med; 1988 Mar; 167(3):873-86. PubMed ID: 3280726
[TBL] [Abstract][Full Text] [Related]
51. A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1.
Storlazzi CT; Anelli L; Albano F; Zagaria A; Ventura M; Rocchi M; Panagopoulos I; Pannunzio A; Ottaviani E; Liso V; Specchia G
Ann Hematol; 2004 Feb; 83(2):78-83. PubMed ID: 14551738
[TBL] [Abstract][Full Text] [Related]
52. Significance of chromosomal alterations and mutations of the N-RAS and TP53 genes in relation to leukemogenesis of acute myeloid leukemia.
Misawa S; Horiike S; Kaneko H; Sasai Y; Ueda Y; Nakao M; Yokota S; Taniwaki M; Fujii H; Nakagawa H; Tsuda S; Kashima K
Leuk Res; 1998 Jul; 22(7):631-7. PubMed ID: 9680114
[TBL] [Abstract][Full Text] [Related]
53. The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia.
de Bustros A; Nelkin BD; Silverman A; Ehrlich G; Poiesz B; Baylin SB
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5693-7. PubMed ID: 2840671
[TBL] [Abstract][Full Text] [Related]
54. Analysis of the p53 gene in myeloid malignancies associated with chromosomal abnormalities involving the short arm of chromosome 17.
Rege-Cambrin G; Gaidano G; Serra A; Scaravaglio P; Guglielmelli T; Guerrasio A; Giovinazzo B; Saglio G
Leukemia; 1994 Apr; 8 Suppl 1():S23-6. PubMed ID: 8152298
[TBL] [Abstract][Full Text] [Related]
55. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia.
Rosson D; Reddy EP
Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic targets in hematopoietic malignancies.
Claus R; Lübbert M
Oncogene; 2003 Sep; 22(42):6489-96. PubMed ID: 14528273
[TBL] [Abstract][Full Text] [Related]
57. Specific detection of Flt3 point mutations by highly sensitive real-time polymerase chain reaction in acute myeloid leukemia.
Scholl S; Krause C; Loncarevic IF; Müller R; Kunert C; Wedding U; Sayer HG; Clement JH; Höffken K
J Lab Clin Med; 2005 Jun; 145(6):295-304. PubMed ID: 15976757
[TBL] [Abstract][Full Text] [Related]
58. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents.
Andersen MK; Christiansen DH; Kirchhoff M; Pedersen-Bjergaard J
Genes Chromosomes Cancer; 2001 May; 31(1):33-41. PubMed ID: 11284033
[TBL] [Abstract][Full Text] [Related]
59. Transposition of the oncogene c-ets-1 in a t(11;19)(q23;p13) cell line transient during clonal evolution of blast crisis chronic myeloid leukemia.
Morris CM; Whitham SE; Fitzgerald PH
Leukemia; 1988 Feb; 2(2):74-8. PubMed ID: 3422701
[TBL] [Abstract][Full Text] [Related]
60. Incidence of MLL rearrangement in acute myeloid leukemia, and a CALM-AF10 fusion in M4 type acute myeloblastic leukemia.
Abdou SM; Jadayel DM; Min T; Swansbury GJ; Dainton MG; Jafer O; Powles RL; Catovsky D
Leuk Lymphoma; 2002 Jan; 43(1):89-95. PubMed ID: 11911106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
